-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Tango Therapeutics, Raises Price Target to $24

Benzinga·03/09/2026 12:55:45
Listen to the news
Stifel analyst Laura Prendergast maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $15 to $24.